Medifast, Inc. (MED) is a publicly traded Consumer Cyclical sector company. As of November 20, 2026, MED trades at $11.50 with a market cap of $136.43M and a P/E ratio of -4.97. MED moved -4.13% today. Year to date, MED is +9.53%; over the trailing twelve months it is +11.36%. Its 52-week range spans $9.22 to $15.46. Analyst consensus is neutral with an average price target of $12.00. Rallies surfaces MED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Medifast Q3 revenue falls 19.4%; forecasts 2026 revenue of $280 million to $300 million: Medifast reported third-quarter revenue of $72.05 million, down 19.4%, and a net loss of $17.51 million as active earning coaches fell nearly 48%. It expects fourth-quarter revenue of $55 million to $75 million and 2026 revenue of $280 million to $300 million.
| Metric | Value |
|---|---|
| Price | $11.50 |
| Market Cap | $136.43M |
| P/E Ratio | -4.97 |
| EPS | $-2.33 |
| Dividend Yield | 1.65% |
| 52-Week High | $15.46 |
| 52-Week Low | $9.22 |
| Volume | 79.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $316.93M |
| Net Income | $-25.60M |
| Gross Margin | 69.24% |
1 analysts cover MED: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.00.